Here, we describe the non-redundant roles of caspase-activated DNase (CAD) and DNasec during apoptosis in the immature B-cell line WEHI-231. These cells induce DNA-ladder formation and nuclear fragmentation by activating CAD during cytotoxic drug-induced apoptosis. Moreover, these apoptotic manifestations are accompanied by inhibitor of CAD (ICAD) cleavage and are abrogated by the constitutive expression of a caspase-resistant ICAD mutant. No such nuclear changes occur during oxidative stress-induced necrosis, indicating that neither CAD nor DNasec functions under necrotic conditions. Interestingly, the DNAladder formation and nuclear fragmentation induced by B-cell receptor ligation occur in the absence of ICAD cleavage and are not significantly affected by the ICAD mutant. Both types of nuclear changes are preceded by the upregulation of DNasec expression and are strongly suppressed by 4-(4,6-dichloro-[1, 3, 5]-triazin-2-ylamino)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-benzoic acid (DR396), which is a specific inhibitor of DNasec. Our results suggest that DNasec provides an alternative mechanism for inducing nuclear changes when the working apoptotic cascade is unsuitable for CAD activation. 3,4 This cellular suicide program allows potentially harmful or redundant cells to be individually eliminated, in order to maintain healthy homeostasis in multicellular organisms.
Here, we describe the non-redundant roles of caspase-activated DNase (CAD) and DNasec during apoptosis in the immature B-cell line WEHI-231. These cells induce DNA-ladder formation and nuclear fragmentation by activating CAD during cytotoxic drug-induced apoptosis. Moreover, these apoptotic manifestations are accompanied by inhibitor of CAD (ICAD) cleavage and are abrogated by the constitutive expression of a caspase-resistant ICAD mutant. No such nuclear changes occur during oxidative stress-induced necrosis, indicating that neither CAD nor DNasec functions under necrotic conditions. Interestingly, the DNAladder formation and nuclear fragmentation induced by B-cell receptor ligation occur in the absence of ICAD cleavage and are not significantly affected by the ICAD mutant. Both types of nuclear changes are preceded by the upregulation of DNasec expression and are strongly suppressed by 4-(4,6-dichloro- [1, 3, 5] -triazin-2-ylamino)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-benzoic acid (DR396), which is a specific inhibitor of DNasec. Our results suggest that DNasec provides an alternative mechanism for inducing nuclear changes when the working apoptotic cascade is unsuitable for CAD activation. During B-lymphocyte development in the bone marrow, somatic gene rearrangements occur at the immunoglobulin (Ig) loci through V(D)J recombination. 1 This produces a diverse repertoire of B cells, and allows the immune system to recognize a wide range of foreign antigens. However, creating such variety carries the risk of generating self-reactive B cells. To avoid autoimmune manifestations, self-reactive B cells can be rendered inactive (anergy), reconstituted in their antigen receptor (receptor editing) or eliminated by apoptosis (clonal deletion) at an immature stage of development. 2 The clonal deletion of self-reactive B cells depends upon the sensitivity of their B-cell receptors (BCRs) to self-antigens. The strong engagement of surface IgM causes immature B cells to exit from the cell cycle and undergo apoptosis. 3, 4 This cellular suicide program allows potentially harmful or redundant cells to be individually eliminated, in order to maintain healthy homeostasis in multicellular organisms. 5 It is distinguished from necrosis by its specific morphologies (such as balloon-cell formation, chromatin condensation, and nuclear fragmentation) and biochemical markers (including the cleavage of death substrates by caspases and the degradation of genomic DNA into nucleosomal fragments). 6, 7 The occurrence of nucleosomal DNA fragmentation is an important feature of apoptosis, and the presence of a ladder configuration in agarose gel electrophoresis provides reliable evidence of this process. 7 Apoptotic signals are initiated by various physiological and pathological stimuli, and are transmitted by the successive activation of several protease cascades, including those of calpains, cathepsins, and caspases. 8, 9 Although the utilization of apical proteases differs depending on the type of apoptotic stimulus, they subsequently promote the activation of downstream effector caspases (caspase-3, caspase-6, and caspase-7), which catalyze the proteolysis of death substrates (such as poly (ADP-ribose) polymerase-1 (PARP-1) and DNA-fragmentation factor 45 (DFF45)/inhibitor of caspase-activated DNase (ICAD)). 8 DFF is a heterodimeric complex of DFF40 and DFF45, which is purified from the S100 fraction of HeLa cells on the basis of its activity to induce DNA-ladder formation in a cell-free apoptosis system. 10 The murine homologs of DFF40 and DFF45 -caspase-activated DNase (CAD) and ICAD, respectively -have been isolated and characterized. 11 CAD exists in living cells as an inactive complex with its natural inhibitor ICAD. Upon apoptosis induction, CAD is released from the complex by the caspase-3-mediated cleavage of ICAD, and catalyzes nucleosomal DNA fragmentation in dying cells. 11 Thus, CAD is considered to have a major role in apoptosis accompanied by caspase-3 activation.
The existence of a nuclear apoptotic Ca 2 þ /Mg 2 þ -dependent DNase has long been suspected. We previously identified and purified the 33-kDa endonuclease DNaseg. 12 Sequence analysis of its complementary DNA (cDNA) confirmed it to be a novel member of the DNase I family. 13 DNaseg differs from the other family members by its ability to catalyze DNA fragmentation during apoptosis. 14, 15 DNaseg induction occurs in C2C12 cells during myogenic differentiation, and its suppression by the stable expression of its antisense RNA reduces DNA-ladder formation in spontaneous apoptosis during differentiation. 16 It is also involved in spontaneous apoptosis during the neuronal differentiation of N1E-115 cells and the NGF-deprivation-induced apoptosis of neuronally differentiated PC12 cells. 17 Thus, DNaseg appears to play an important role in apoptosis during differentiation and specific developmental stages. As mentioned above, the apoptosis of self-reactive B cells occurs at a specific stage of B-cell development. Furthermore, DNaseg is expressed at high levels in the bone marrow where clonal deletion takes place. 14 Based on these facts, we proposed that the BCR-induced apoptosis of immature B cells might involve DNaseg.
The current paper describes the specific expression of DNaseg in immature B cells, and assesses its role in apoptotic DNA fragmentation induced by BCR cross-linking. We also report on the non-redundant roles of CAD and DNaseg in apoptosis in the murine immature B-cell line WEHI-231.
Results
Expression profiles of CAD and DNasec in murine B cells. The expression levels of two apoptotic endonucleases, CAD and DNaseg, were analyzed by Northern blots in several murine B-cell lines at various maturation stages. As shown in Figure 1a , CAD and ICAD were expressed at constant levels in the B cells. However, the DNaseg expression level differed depending on the developmental stage. DNaseg mRNA was detected at high levels in immature B cells (WEHI-231 and CH31). However, although lower DNaseg expression levels were detected in the B-cell lines with mature phenotypes (WEHI-279 and A20), no specific hybridization was detected in pre-B cells or plasma cells (J558L).
The high DNaseg expression level in immature B cells was confirmed in primary cells isolated from the spleen. Briefly, the mice were exposed to a sublethal dose of X-rays and Thy1.1-depleted spleen B cells were removed on day 13 post-irradiation. Approximately, 90% of the cells were positive for B220; the relative amounts of the immature phenotypes (IgM hi IgD lo ) were 10 and 50% in the B-cell preparations obtained from the control and irradiated mice, respectively (Figure 1b) . Figure 1c shows the results of the activity gel assay; the band representing DNaseg activity was faint in the control preparation, whereas it was distinct in the preparation enriched with immature B cells.
These results revealed that the expression patterns of CAD and DNaseg differed significantly during B-cell development: CAD was expressed at a constant level throughout B-cell ontogeny, whereas DNaseg had a high expression level in immature B cells alone.
CAD is responsible for DNA and nuclear fragmentation during cytotoxic drug-induced apoptosis in WEHI-231 cells. The above-mentioned observations suggest that the utilization of CAD and DNaseg is dependent upon the type of apoptotic stimulus in immature B cells. CAD appears to catalyze DNA fragmentation during apoptosis independent of the developmental stage, whereas DNaseg is specifically involved in the apoptosis of immature B cells. The overexpression of a caspase-resistant form of ICAD selectively interferes with CAD activation without affecting DNaseg activity. 17 We therefore established WEHI-231 cells that were stably transfected with an expression vector for a caspase-resistant ICAD mutant (Figure 2a) , and used them to define the contributions of CAD and DNaseg in apoptotic DNA-ladder formation. We initially examined the effects of CAD inhibition on apoptosis induced by cytotoxic drugs. Figure 2b shows the time course of apoptotic DNA fragmentation induced by staurosporine (STS) treatment. A nucleosomal DNA ladder was clearly produced in mock-transfected control cells (Puro), and this process was correlated with the disappearance of ICAD. By contrast, no ladder formation was observed in cells expressing the mutant ICAD (ICAD-CR). In both the control and ICAD-CR cells, the kinetics of PARP-1 cleavage were similar ( Figure 2b) . Thus, the overexpression of ICAD-CR was shown to suppress DNA fragmentation without affecting apoptotic death. Similar results were obtained with other cytotoxic drugs (etoposide (Etp), cycloheximide (CHX), thapsigargin (Tg), and tunicamycin (Tm)) ( Figure 2b ).
We also analyzed the effects of ICAD-CR on cellular and nuclear morphological changes (Figure 2c ). Differential interference contrast (DIC) microscopy showed a balloon-like morphology, whereas the fluorescence field revealed extensive nuclear fragmentation in control cells treated with STS. Although the balloon-cell morphology was generally observed in ICAD-CR cells, the sequence of nuclear morphological changes was arrested at chromatin condensation and did not proceed to nuclear fragmentation. These findings indicate that CAD activation is required for both DNA-ladder formation and nuclear fragmentation during cytotoxic drug-induced apoptosis in WEHI-231 cells.
Neither CAD nor DNasec is activated during oxidative stress-induced necrosis in WEHI-231 cells. Oxidative stress caused by H 2 O 2 induces both apoptosis and necrosis in a dose-dependent manner. We therefore examined the roles of CAD and DNaseg in oxidative stressinduced apoptosis and necrosis in WEHI-231 cells. Low doses of H 2 O 2 (B50-100 mM) induced apoptotic DNA fragmentation and PARP-1 cleavage in the control cells ( Figure 3a ). The ladder formation was accompanied by ICAD cleavage, and was inhibited by ICAD-CR (Figure 3a) . Dying cells retained their membrane integrity and exhibited similar morphological changes to those induced by STS (data not shown). These results indicate that H 2 O 2 at doses up to 100 mM promotes CAD activation and apoptotic death in WEHI-231 cells; the cells undergo necrosis when treated with H 2 O 2 at higher doses (B0.3-1 mM). Microscopic analysis revealed necrotic characteristics, such as collapsed cellular morphologies, and an absence of nuclear changes ( Figure 3b ). The loss of membrane integrity was confirmed by a vital dye-exclusion test (data not shown). Under necrotic conditions, both the control and ICAD-CR To determine whether the activation of CAD occurred in response to BCR ligation, we performed Western blot analysis to detect the caspase-mediated cleavage of ICAD. As shown in Figure 5 , apoptosis caused by both STS treatment and BCR cross-linking was accompanied by oligonucleosomal DNA fragmentation and PARP-1 cleavage. As expected, the disappearance of intact ICAD correlated well with the onset of DNA fragmentation in STS-induced apoptosis. By contrast, ICAD cleavage was barely observed during BCR ligationinduced apoptosis in WEHI-231 cells (Figure 5b) . This explained the observation that ICAD-CR expression failed to suppress DNA fragmentation and nuclear morphological changes during apoptosis induced by BCR ligation. These results indicate that CAD does not play a major role in BCRmediated apoptosis in WEHI-231 cells.
Upregulation of DNasec upon BCR crosslinking in WEHI-231 cells. BCR ligation alters the expression levels of certain apoptosis-related molecules, and thus plays an important role in the control of BCR-mediated apoptosis in immature B cells. [18] [19] [20] We therefore used the reverse transcription-polymerase chain reaction (RT-PCR) to investigate the changes in CAD and DNaseg expression levels in response to BCR ligation in WEHI-231 cells. A time course study revealed that the expression of CAD was unaffected by BCR signaling. By contrast, the DNaseg expression level increased shortly after BCR ligation, remained high for up to 6 h, and then decreased until 12 h, which coincided with the onset of apoptosis (Figure 6a) . Quantitative real-time PCR revealed that DNaseg expression had increased approximately sixfold at 3 h post-BCR ligation in both the control and ICAD-CR cells (Figure 6b ). The activation of DNaseg expression was also confirmed at the protein level by an activity gel assay (Figure 6a, bottom panel) . Thus, BCR ligation was shown to induce the upregulation of DNaseg before the onset of apoptosis.
Inhibitor of DNasec suppresses nucleosomal ladder formation and nuclear fragmentation during BCRmediated apoptosis in WEHI-231/ICAD-CR cells. We recently found that 4-(4,6-dichloro-[1, 3, 5]-triazin-2-ylamino)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-benzoic acid (DR396) strongly inhibited DNaseg in vitro. Importantly, DR396 had little effect on DNase I, which is structurally related to DNaseg, under the same assay conditions. Furthermore, DR396 selectively suppressed DNasegmediated DNA-ladder formation, but not that induced by CAD, at the cellular level. 21 We thus utilized DR396 to evaluate the role of DNaseg in BCR-mediated apoptosis. Control (Puro) and ICAD-CR cells were stimulated with an anti-IgM antibody in the presence or absence of DR396. As shown in Figure 7a , DR396 strongly suppressed nucleosomal ladder formation without affecting the caspase-mediated cleavage of PARP-1, suggesting that it inhibited the functional apoptotic DNase without affecting the other apoptotic processes activated by BCR ligation. Although ladder formation was weakly detected in the control cells, DR396 almost completely suppressed the BCR-mediated DNA fragmentation in ICAD-CR cells. A control experiment showed that DR396 alone at doses up to 100 mM had no toxic effect on the cells (Figure 7a ). Microscopic analysis revealed that DR396 also interfered with the nuclear fragmentation induced by BCR crosslinking in ICAD-CR cells (Figure 7b ). Based on the specificity of DR396 and the fact that CAD was barely activated in ICAD-CR cells, we concluded that both nucleosomal ladder formation and nuclear fragmentation in BCR-mediated apoptosis were largely induced by DNaseg in WEHI-231 cells.
Discussion
We previously investigated the roles of CAD and DNaseg in cells that predominantly expressed either of these DNases; 16, 17 however, it remained unclear how they contributed to apoptotic DNA fragmentation when they were expressed simultaneously. In the current study, we demonstrated that CAD and DNaseg are both expressed in WEHI-231 cells, and are selectively utilized for nucleosomal DNA fragmentation depending on the cause of apoptosis.
Apoptotic DNA fragmentation induced by cytotoxic drugs was catalyzed by CAD. This apoptotic ladder formation was completely suppressed by the expression of ICAD-CR . Apoptotic stimulation by cytotoxic drugs induces the activation of caspase-3 in various types of cell, 22 and was shown here to promote ICAD cleavage in WEHI-231 cells (Figure 5b) . Thus, these drugs appeared to induce apoptosis in conjunction with CAD activity. Unexpectedly, we found no evidence of the involvement of DNaseg in chemically induced apoptosis in WEHI-231 cells. To date, several groups have independently reported that ectopically expressed DNaseg is activated by cytotoxic drugs and induces DNA fragmentation in dying cells. 14, 15, 23, 24 Furthermore, STS has been shown to produce DNA-ladder formation by activating endogenous DNaseg in neuronally differentiated N1E-115 cells. 17 The activation of DNaseg expression occurs in certain cultured cell lines, such as C2C12, N1E-115, and PC12 cells, when they are exposed to differentiation conditions. 16, 17 However, notably, the expression level of DNaseg in unstimulated WEHI-231 cells was more than 10-times higher than the levels induced in the above-mentioned cells during differentiation (data not shown). Therefore, cells that constitutively express DNaseg at high levels might have inherent protective mechanisms to keep its activity under strict control, and might require specific stimuli to allow it to function in apoptotic DNA fragmentation. This idea is supported by the observation that DNaseg fails to catalyze DNA fragmentation in WEHI-231 cells that are degraded by necrotic stimuli (Figure 3) .
We have shown that BCR-mediated apoptosis utilizes a unique DNA-fragmentation mechanism, which differs from that induced by cytotoxic drugs. DR396, but not ICAD-CR, effectively suppressed BCR-mediated apoptotic DNA fragmentation, indicating that the primary apoptotic DNase in this case is DNaseg. The clonal deletion of self-reactive B cells occurs in immature B cells in which DNaseg is highly expressed. This temporal correlation provides further evidence of DNaseg involvement in BCR-mediated apoptosis.
Among the 14 caspases that occur in mammals, three (caspase-3, caspase-6, and caspase-7) act as executioners during the late stage of apoptosis.
8 Caspase-7 is thought to be the most important caspase in BCR-mediated apoptosis (Figure 8a) . 25, 26 BCR ligation induces the selective activation of caspase-7 via two independent cascades: a mitchondria caspase-9 pathway and a calpain pathway. 26, 27 Calpain, which is a Ca 2 þ -dependent cysteine protease, is activated upon BCR ligation and catalyzes the processing of procaspase-7 into its active form. 26 BCR ligation also triggers a sustained Ca 2 þ influx in WEHI-231 cells, which is thought to be an important trigger of calpain activation. 28 Concomitant signaling through CD40 is known to rescue WEHI-231 cells from BCR-mediated apoptosis. 29 Importantly, CD40 ligation induces the expression of the Bcl-2-like antiapoptotic protein A1 and the endogenous calpain inhibitor calpastatin. 26, 30 A1 and calpastatin inhibit caspase-9 activation and calpain activity, respectively, thereby interfering with the activation of caspase-7.
Generally, caspase-3 is the primary executioner during mammalian cell apoptosis. 22 However, there is growing evidence that BCR-mediated WEHI-231 apoptosis is not accompanied by caspase-3 activation (Figure 8a) . 25, 26, 31 This is supported by the fact that immature B cells from caspase-3-deficient mice undergo normal apoptosis. 32 Both caspase-3 and caspase-7 catalyze the cleavage of PARP-1; however, the former cleaves ICAD more effectively in vitro, and endogenous caspase-7 barely promotes CAD activation in vivo. 33, 34 These observations agree with our finding that PARP-1 cleavage is observed in both cytotoxic drug-mediated and BCR-mediated apoptosis, whereas the disappearance of intact ICAD occurs only in the former. Thus, WEHI-231 cells might primarily utilize DNaseg during BCR-mediated apoptosis, because the cascade activated by BCR ligation is apparently less preferable for CAD activation. Elevated intracellular Ca 2 þ levels caused by BCR ligation might also affect the choice of apoptotic DNase, because this is an important cofactor for DNaseg activity. 14 We do not suggest that BCR-mediated DNA fragmentation is catalyzed exclusively by DNaseg, because DNA-ladder formation is slightly impaired in ICAD-CR cells (Figure 4a ) and might not be completely suppressed by DR396 in parental WEHI-231 cells (Figure 7a) . Thus, trace amounts of CAD might also be activated during BCR-mediated apoptosis and partially contribute to DNA-ladder formation.
To clarify the role of caspase-7 in BCR-mediated DNaseg activation, we tested the effects of the pan-caspase inhibitor z-VAD-fmk, and the specific inhibitor for caspase-3 and caspase-7 DEVD-fmk, on WEHI-231 apoptosis. z-VAD-fmk suppressed both PARP-1 cleavage and DNA fragmentation in a dose-dependent manner (Figure 8b) . Moreover, z-VAD-fmk rescued the BCR-stimulated cells from death (Figure 8c) . These results suggest that activation of a z-VAD-sensitive caspase is essential for the onset of BCR-mediated apoptosis. However, these data failed to reveal the importance of caspase-7 for BCR-mediated DNaseg activation, because the absence of DNA fragmentation caused by z-VAD-fmk is probably a consequence of the inhibition of cell death. By contrast, DEVD-fmk inhibited PARP-1 cleavage without affecting the rate of BCR-mediated cell death (Figure 8c ). DNA-ladder formation was slightly suppressed, provably owing to the inhibition of CAD activation, but remained similar to that observed in ICAD-CR cells (Figures 4a and 7a ). Based on these results, together with the fact that STS-induced apoptosis does not activate DNaseg (Figure 2b ) regardless of the occurrence of caspase-7 activation (Figure 8a ), we concluded that caspase-7 does not have a significant role in BCR ligation-induced DNaseg activation.
Nuclear morphological changes have been used to define apoptotic cell death, and can be induced by acinus-dependent and DNase-dependent mechanisms. 35, 36 In the latter, the nuclear changes occur in a sequential manner: chromosomal DNA initially accumulates around nuclear envelopes (stage I chromatin condensation) and is then fragmented into highly packed round masses (stage II chromatin condensation or nuclear fragmentation). 36 CAD is indispensable for stage II chromatin condensation, as DT40 cells carrying a cad À/À mutation undergo stage I chromatin condensation but fail to proceed to stage II. 37 Although it remains unclear whether CAD activity is required for stage I chromatin condensation, its essential role in nuclear morphological changes has been confirmed in cells prepared from ICAD-deficient mice. 38 Our results obtained using cytotoxic drugs support these previous observations. However, we found that ICAD-CR failed to suppress stage II chromatin condensation during BCRmediated apoptosis in WEHI-231 cells. We showed that BCR ligation-induced DNA-ladder formation was catalyzed by DNaseg, such that DNA fragmentation was scarcely affected by ICAD-CR. Our results demonstrate the ability of DNaseg to induce nuclear fragmentation or stage II chromatin condensation during apoptosis. Our data also indicate that the critical factor for stage II chromatin condensation is the occurrence of nucleosomal DNA fragmentation per se, rather than a specific type of apoptotic DNase being required for this process.
Our study has revealed that nucleosomal DNA fragmentation in WEHI-231 cells is catalyzed by CAD or DNaseg depending on the cause of apoptosis. Apoptotic cells are engulfed by macrophages or neighboring cells, and are rapidly eliminated in vivo. If the genetic information of dying cells persists, it might transform phagocytes via horizontal transfer of the engulfed genes. 39 Furthermore, defects in DNA waste clearance can cause serious pathological conditions (such as autoimmune diseases, lethal anemia, and impaired thymic development) by disturbing the immune system. 7 Therefore, preparing for possible death by installing multiple apoptotic DNases could be an excellent cellular strategy to avoid such hazardous situations.
Materials and Methods
Cell culture. Murine B cell lines (18- 81 (pre-B) , WEHI-231 (immature B), CH31 (immature B), WEHI-279 (mature B), A20 (mature B), and J558L (plasma)) were cultured in RPMI-1640 supplemented with 10% fetal calf serum, 50 mM of 2-mercaptoethanol, 100 U/ml penicillin, and 100 mg/ml streptomycin.
Preparation of spleen B cells. C57BL/6 mice (18 weeks old) were irradiated with X-rays at 5 Gy to remove all lymphocytes. After 13 days of irradiation, the spleens in which newly generated IgM high IgD low B cells had accumulated were removed from the irradiated and age-matched control animals. The spleen cells were suspended in FACS buffer (Dulbecco's modified phosphate-buffered saline containing 0.1% bovine serum albumin, and 0.1% sodium azide), passed through a 70-mm pore size nylon filter (Falcon), and washed twice with the same buffer. After removal of the red blood cells by suspension in a hypotonic buffer (0.15 M NH 4 Cl, 1 mM KHCO 3 , and 0.1 mM EDTA (pH 7.3)), they were further treated with an antiThy1.1 antibody (Pharmingen) in the presence of a Low-Tox-M rabbit complement (Cedarlane), and the T cells were removed. The resulting cells were washed twice, resuspended in FACS buffer and subjected to flow cytometry or an activity gel assay.
Cell staining and flow cytometry. The spleen B cells were analyzed by flow cytometry to examine the expression profiles of the indicated cell-surface antigens. Single-cell suspensions, prepared as described above, were incubated with antibodies specific for the indicated antigens for 30 min on ice. The antibodies used were as follows: PE-anti B220 (1 : 1000 dilution; Pharmingen); FITC-anti-CD3 (1 : 1000 dilution; Pharmingen); PE-anti-IgM (1 : 1000 dilution; Southern Biotechnology); and FITC-anti-IgD (1 : 1000 dilution; Southern Biotechnology). The resulting cells were washed twice with the same buffer and analyzed by FACScan using Cellquest software (Becton Dickinson).
Gene-expression analyses. Northern blot analysis was performed as described previously, with some modifications. 13 Briefly, 15 mg total RNA was separated by 1% agarose-formamide gel electrophoresis and transferred to a Hybond-N þ membrane (Amersham). The blot was hybridized with a 32 P-labeled cDNA fragment for the entire open reading frame of mouse DNaseg (GenBank U76110) using PerfectHyb hybridization solution (Toyobo), and was visualized using a BAS1500 imaging system (Fuji Film). The resulting blot was boiled in a stripping solution (sterile H 2 O containing 0.5% SDS) for 5 min, and was repeatedly hybridized for ICAD (GenBank AB009375) and CAD (GenBank AB009377). RT-PCR analysis was performed as described previously. 16 PCR amplification was carried out for the indicated number of cycles, each of which consisted of denaturation at 941C for 30 s, annealing at 621C for 30 s, and extension at 721C for 1 min. The primers used were as follows: CAD (34 cycles), To quantify the DNaseg transcripts, real-time PCR analysis was performed using a QuantiTect SYBR Green PCR kit (Qiagen) in an ABI Prism 7700 sequence detector (Applied Biosystems). All assays were performed in triplicate and normalized for b-actin mRNA.
Assay for DNasec activity. DNaseg activity was analyzed by an activity gel assay as described previously. 16 The in-gel reaction was performed in a reaction buffer (10 mM Tris-HCl (pH 7.8), 1 mM 2-mercaptoethanol, 3 mM CaCl 2 , and 3 mM MgCl 2 ) overnight at 371C. After observing the DNase activity, the resulting gel was subjected to Coomassie Brilliant Blue staining to confirm equal lane loadings (data not shown).
Western blot analysis. Western blot analysis was performed using rabbit polyclonal antibodies for PARP-1 (1 : 1000 dilution; Wako), ICAD (1 : 1000 dilution;
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